http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2034848-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5152bf8b1b8998a379a1d54e94cd7fc
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-073
filingDate 1992-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1995-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c761240246fe91fbeb1c49bb1e11c38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f4a9484ea408c18dd6aeee838af2378
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74cf556a6d7a0d5123d6b265e8d41b22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66b1e581f2f72ba07228478e955d93ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d63e0a0f3e608efa3a7d9fac5b1c2a68
publicationDate 1995-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2034848-C1
titleOfInvention Method of azidothymidine synthesis
abstract FIELD: organic chemistry. SUBSTANCE: product: 1-(3′-azido-2,3′-dihydroxy-D-erythro-pentofuranosyl)thymidine, yield is 50%. Content of basic substance is 97% . Reagent 1: 5′-O-benzoyl-2,3′-anhydroxythymidine. Reagent 2: sodium azide in the presence of lithium chloride and ammonium chloride at the ratio of all reagents 1:1-1.1:0.25-0.3:0.3:0.35, respectively, at 98-102 C following by treatment with methanol and diethylamine at the ratio 1:1. Preparation is used for AIDS treatment. EFFECT: improved method of synthesis. 3 cl, 1 tbl
priorityDate 1992-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6420096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451203358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415970552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518507
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID433294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449205589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450422860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455502157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451936144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409028757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID457982

Total number of triples: 38.